Stock listing
BOATS:NPCE NeuroPace, Inc. Stock
US listing (BOATS) of NeuroPace, Inc. · home listing NASDAQ:NPCE
Follow NeuroPace, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NPCE
$7.95 USD -0.27 (-3.3%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NPCE
- Day range
- $7.85 – $8.29 USDNov 20, 2026
- Volume
- 749,375 sharesNov 20, 2026
- Market cap
- $273.9M USDAt the close on Nov 20, 2026 · price × 34.45M shares outstanding
- 52-week range
- $5.46 – $19.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2.74M USDMedian day 125,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NPCE · Home | $7.95 USD | -0.27 (-3.3%) | 749,375 | $7.97 | $8.29 | $7.845 | $8.22 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NPCE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.95 | -0.27 | -3.3% | $7.97 | $8.29 | $7.845 | 749,375 | |
| $8.22 | +0.02 | +0.2% | $8.56 | $8.56 | $7.93 | 307,220 | |
| $8.20 | +0.23 | +2.9% | $7.825 | $8.71 | $7.63 | 679,806 | |
| $7.97 | +0.41 | +5.4% | $7.49 | $8.18 | $7.05 | 1,768,216 | |
| $7.56 | -4.46 | -37.1% | $6.25 | $7.71 | $5.46 | 6,105,800 | |
| $12.02 | -0.50 | -4.0% | $12.52 | $12.67 | $11.90 | 156,700 | |
| $12.52 | -0.17 | -1.3% | $12.81 | $12.94 | $12.46 | 89,300 | |
| $12.69 | -0.43 | -3.3% | $13.09 | $13.35 | $12.65 | 133,700 | |
| $13.12 | +0.62 | +5.0% | $12.81 | $13.48 | $12.80 | 235,700 | |
| $12.50 | -0.19 | -1.5% | $12.69 | $13.01 | $12.14 | 128,400 | |
| $12.69 | -0.65 | -4.9% | $13.41 | $13.41 | $12.40 | 122,000 | |
| $13.34 | +1.03 | +8.4% | $12.79 | $13.94 | $12.79 | 227,900 | |
| $12.31 | -0.03 | -0.2% | $12.42 | $12.64 | $12.00 | 199,800 | |
| $12.34 | +0.04 | +0.3% | $12.50 | $12.69 | $12.31 | 120,500 | |
| $12.30 | -0.71 | -5.5% | $13.01 | $13.10 | $12.25 | 80,900 | |
| $13.01 | +0.08 | +0.6% | $13.12 | $13.45 | $12.94 | 104,600 | |
| $12.93 | -0.09 | -0.7% | $12.83 | $13.33 | $12.74 | 189,500 | |
| $13.02 | +0.03 | +0.2% | $13.03 | $13.16 | $12.91 | 67,200 | |
| $12.99 | +0.08 | +0.6% | $12.90 | $13.22 | $12.64 | 67,300 | |
| $12.91 | -0.23 | -1.8% | $12.76 | $13.07 | $12.76 | 69,100 | |
| $13.14 | +0.09 | +0.7% | $13.05 | $13.43 | $12.92 | 97,900 | |
| $13.05 | -0.46 | -3.4% | $13.51 | $13.69 | $13.03 | 64,200 | |
| $13.51 | +0.74 | +5.8% | $12.84 | $13.53 | $12.81 | 116,900 | |
| $12.77 | +0.53 | +4.3% | $12.28 | $12.80 | $12.16 | 117,400 | |
| $12.24 | -0.54 | -4.2% | $12.85 | $12.85 | $12.13 | 156,300 | |
| $12.78 | +0.22 | +1.8% | $12.51 | $13.00 | $12.51 | 86,600 | |
| $12.56 | -0.12 | -0.9% | $12.58 | $13.04 | $12.48 | 90,000 | |
| $12.68 | -0.32 | -2.5% | $13.06 | $13.27 | $12.68 | 66,800 | |
| $13.00 | +0.33 | +2.6% | $12.52 | $13.02 | $12.48 | 63,300 | |
| $12.67 | +0.28 | +2.3% | $12.39 | $12.70 | $12.38 | 72,500 | |
| $12.39 | -0.37 | -2.9% | $12.66 | $12.66 | $12.28 | 142,600 | |
| $12.76 | +0.09 | +0.7% | $12.58 | $13.06 | $12.51 | 127,200 | |
| $12.67 | -0.55 | -4.2% | $13.38 | $13.38 | $12.66 | 83,000 | |
| $13.22 | +0.52 | +4.1% | $12.64 | $13.26 | $12.50 | 149,400 | |
| $12.70 | -0.45 | -3.4% | $13.34 | $13.34 | $12.68 | 120,400 | |
| $13.15 | -0.61 | -4.4% | $13.81 | $13.81 | $13.05 | 197,400 | |
| $13.76 | -0.18 | -1.3% | $14.02 | $14.06 | $13.73 | 120,900 | |
| $13.94 | -0.21 | -1.5% | $14.14 | $14.45 | $13.77 | 100,600 | |
| $14.15 | +0.09 | +0.6% | $14.01 | $14.18 | $13.75 | 134,300 | |
| $14.06 | +0.09 | +0.6% | $13.95 | $14.18 | $13.75 | 231,400 | |
| $13.97 | -0.24 | -1.7% | $14.21 | $14.21 | $13.59 | 186,000 | |
| $14.21 | -0.50 | -3.4% | $14.71 | $14.87 | $14.17 | 166,400 | |
| $14.71 | +0.17 | +1.2% | $14.75 | $14.94 | $14.54 | 160,200 | |
| $14.54 | +0.26 | +1.8% | $14.36 | $14.66 | $14.12 | 71,700 | |
| $14.28 | +0.13 | +0.9% | $14.17 | $14.56 | $14.05 | 235,500 | |
| $14.15 | +0.05 | +0.4% | $14.34 | $14.34 | $13.97 | 107,800 | |
| $14.10 | -0.15 | -1.1% | $14.28 | $14.57 | $14.04 | 116,100 | |
| $14.25 | -0.34 | -2.3% | $14.48 | $14.49 | $14.05 | 96,800 | |
| $14.59 | +0.55 | +3.9% | $14.01 | $14.66 | $13.95 | 125,900 | |
| $14.04 | +0.17 | +1.2% | $14.04 | $14.13 | $13.82 | 107,500 | |
| $13.87 | -0.63 | -4.3% | $14.46 | $14.47 | $13.83 | 73,000 | |
| $14.50 | -0.26 | -1.8% | $14.68 | $14.77 | $14.41 | 78,600 | |
| $14.76 | -0.14 | -0.9% | $14.65 | $15.10 | $14.54 | 105,200 | |
| $14.90 | +0.15 | +1.0% | $14.62 | $14.90 | $14.47 | 92,300 | |
| $14.75 | -0.44 | -2.9% | $15.25 | $15.48 | $14.49 | 141,500 | |
| $15.19 | +0.45 | +3.1% | $14.75 | $15.56 | $14.68 | 163,700 | |
| $14.74 | +0.09 | +0.6% | $14.70 | $14.86 | $14.52 | 132,800 | |
| $14.65 | +0.24 | +1.7% | $14.41 | $14.67 | $14.24 | 148,300 | |
| $14.41 | +0.28 | +2.0% | $14.09 | $14.55 | $13.76 | 129,400 | |
| $14.13 | -0.55 | -3.7% | $14.60 | $14.81 | $14.07 | 148,100 | |
| $14.68 | +0.52 | +3.7% | $14.23 | $14.86 | $14.10 | 172,800 | |
| $14.16 | +0.17 | +1.2% | $14.04 | $14.27 | $13.97 | 153,402 | |
| $13.99 | -0.04 | -0.3% | $14.10 | $14.48 | $13.96 | 117,660 | |
| $14.03 | +0.01 | +0.1% | $14.14 | $14.22 | $13.87 | 116,000 | |
| $14.02 | -0.62 | -4.2% | $14.35 | $14.60 | $13.56 | 191,800 |
- Ticker
- BOATS:NPCE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance
Latest earnings call · Nov 12, 2026
NeuroPace (NASDAQ:NPCE) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 11, 2026
Q2 2026 Earnings Presentation
Earnings · 31 slides
Latest news
NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance
Nov 12, 2026
Closed $7.56 (-37.1%) on Nov 13, 2026
NeuroPace to Report Third Quarter 2026 Financial Results on November 12, 2026
Oct 29, 2026
Closed $12.30 (-5.5%) on Oct 30, 2026
NeuroPace to Participate in 2026 Cantor Global Healthcare Conference
Sep 1, 2026
Closed $15.19 (+3.1%) on Sep 2, 2026
NeuroPace to Participate in Wells Fargo 21st Annual Healthcare Conference
Aug 31, 2026
Closed $14.74 (+0.6%) on Sep 1, 2026
NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Aug 11, 2026
Closed $14.56 (-3.3%) on Aug 12, 2026
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
Jul 28, 2026
Closed $15.31 (+0.1%) on Jul 28, 2026
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
May 29, 2026
Closed $16.54 (-4.9%) on May 29, 2026
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
May 29, 2026
Closed $16.54 (-4.9%) on May 29, 2026
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
May 12, 2026
Closed $15.81 (+0.1%) on May 13, 2026
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026
Apr 29, 2026
Closed $16.86 (+1.9%) on Apr 30, 2026
NeuroPace, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 21 in the last 12 months · 118 in all · newest Nov 12, 2026 · oldest 2021
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 12, 2026
- Decks
- 8 decks · latest Aug 11, 2026
Where NeuroPace, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NPCE · Home listing | NASDAQ | United States | USD |
| BOATS:NPCE · This page | BOATS | United States | USD |
Valuation
EV/sales 2.8× against a median of 2.6×: 6th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $283.8M USD
- P/E
- Loss
- EV/sales
- 2.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 23.8×
- Gross margin
- 78.9%
- Operating margin
- −11.5%
- Net margin
- −18.4%
- Debt to equity
- 5.2×
- Beta vs S&P 500
- 1.23
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| NeuroPace, Inc. · NASDAQ:NPCE | US$273.9M | US$283.8M | n/a | 2.8× | n/a | 23.8× | −18.4% | 5.2× | 1.23 |
| Chongqing Xishan Science and Technology Co., Ltd. Class A · SSE:688576 | US$301.5M | US$216.0M | n/a | 5.2× | n/a | 1.2× | −19.2% | 0.0× | n/a |
| Sanara MedTech Inc. · NASDAQ:SMTI | US$299.1M | US$329.0M | n/a | 2.9× | 34.4× | 39.0× | −2.7% | 6.1× | 0.49 |
| Peijia Medical Ltd. · HKEX:9996 | US$297.8M | US$280.7M | n/a | 2.6× | n/a | 1.1× | −28.5% | 0.3× | n/a |
| Jiangsu Apon Medical Technology Co. Ltd. Class A · SZSE:300753 | US$293.3M | US$281.1M | n/a | 5.8× | n/a | 3.0× | −9.1% | 0.0× | n/a |
| Carvolix · EURONEXT:CVX | US$293.0M | US$306.6M | n/a | n/a | n/a | 6.2× | n/a | 0.5× | n/a |
| Treace Medical Concepts, Inc. · NASDAQ:TMCI | US$282.6M | US$302.8M | n/a | 1.5× | n/a | 4.6× | −27.4% | 1.0× | 2.03 |
| PT Jayamas Medica Industri Tbk · IDX:OMED | US$257.3M | US$192.4M | 10.5× | 1.4× | 6.4× | 1.6× | 18.2% | 0.1× | n/a |
| SS Innovations International Inc. · NASDAQ:SSII | US$254.7M | US$264.8M | n/a | 5.8× | n/a | 5.1× | −31.5% | 0.4× | 0.89 |
| Orthofix Medical Inc. · NASDAQ:OFIX | US$247.4M | US$382.9M | n/a | 0.5× | 11.8× | 0.6× | −5.4% | 0.5× | 1.09 |
| Dentium Co., Ltd. · KRX:145720 | US$242.5M | US$224.9M | 10.8× | 0.9× | 3.1× | 0.6× | 8.6% | 0.1× | n/a |
| Median of the others | US$287.8M | US$280.9M | 10.7× | 2.6× | 9.1× | 2.3× | −9.1% | 0.4× | 0.99 |
Forecasts
6 strong buy · 4 hold · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.33 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.41 · 6 analysts
- Revenue, year to Dec 2026
- 91.29M · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Joel D. Becker | CEO and Board Member |
| Patrick F. Williams | Chief Financial Officer |
| Leah Akin | General Counsel & Corporate Secretary |
| Scott Schaper | Head of Investor Relations |
| Martha Morrell | Chief Medical Officer |
Board
| Director | Role |
|---|---|
| Joel D. Becker | CEO and Board Member |
Events
Calls
| Call | When | Status |
|---|---|---|
| NeuroPace (NASDAQ:NPCE) Q3 2026 Earnings Call | Thu, Nov 12, 2026 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q2 2026 Earnings Call | Tue, Aug 11, 2026 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q1 2026 Earnings Call | Tue, May 12, 2026 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q4 2025 Earnings Call | Tue, Mar 03, 2026 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q2 2025 Earnings Call | Tue, Aug 12, 2025 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q1 2025 Earnings Call | Tue, May 13, 2025 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q4 2024 Earnings Call | Wed, Jan 15, 2025 · 7:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 4:30 PM ET | Replay |
| NeuroPace (NASDAQ:NPCE) Q2 2024 Earnings Call | Tue, Aug 13, 2024 · 4:30 PM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 · After close | −37.1% |
| Q2 2026 | Aug 11, 2026 · After close | −3.3% |
| Q1 2026 | May 13, 2026 | −0.1% |
| Q4 2025 | Mar 3, 2026 · After close | +0.9% |
| Q3 2025 | Nov 4, 2025 · After close | +38.1% |
| Q2 2025 | Aug 12, 2025 · After close | +2.1% |
| Q1 2025 | May 13, 2025 · After close | +20.5% |
| Q4 2024 | Mar 3, 2025 · After close | +0.9% |
| Q3 2024 | Nov 12, 2024 · After close | +28.1% |
| Q2 2024 | Aug 13, 2024 · After close | −7.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 8, 2024 · After close | −36.8% |
| Q4 2023 | Mar 5, 2024 · After close | −1.6% |
| Q3 2023 | Nov 6, 2023 · After close | −1.8% |
| Q2 2023 | Aug 8, 2023 · After close | +9.8% |
| Q1 2023 | May 4, 2023 · After close | −0.8% |
| Q4 2022 | Mar 2, 2023 · After close | −2.4% |
| Q3 2022 | Nov 8, 2022 · After close | −17.0% |
| Q2 2022 | Aug 11, 2022 · After close | −7.0% |
| Q1 2022 | May 12, 2022 · After close | −1.8% |
| Q4 2021 | Mar 10, 2022 · After close | +6.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 31 slides | Aug 11, 2026 |
| J.P. Morgan 44th Annual Healthcare Conference 2026 | Conference | 28 slides | January 2026 |
| Q1 2025 Earnings Presentation | Earnings | 27 slides | May 13, 2025 |
| Investor Day (January 2025) | Investor day | 126 slides | Jan 28, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference (January 2025) | Conference | 28 slides | January 2025 |
| Investor Presentation (January 2024) | Investor deck | 28 slides | Jan 8, 2024 |
| JP Morgan Healthcare Conference 2023 | Conference | 20 slides | Jan 9, 2023 |
| Investor Presentation (January 2022) | Investor deck | 19 slides | Jan 11, 2022 |
Financings
| Raise | Date |
|---|---|
| At-the-market programme of at-the-market (ATM) offering program Cancelled: at-the-market programme | Feb 20, 2025 |
| Public offering of common stock Closed: US$74.8M raised · US$10 a share · J.P. Morgan +4 Dealers: J.P. Morgan (co-lead), Cantor (co-lead), Wells Fargo Securities (co-lead), Leerink Partners (co-lead), Lake Street Capital Markets Use of proceeds: About $49.5 million to repurchase 5,270,845 shares held by KCK Ltd.; rest for general corporate purposes incl. R&D, SG&A, debt reduction, working capital | Feb 18, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$17.00 a share on Apr 21, 2021.
- Price
- US$17.00 a share
- Shares offered
- 6,000,000 shares of common stock
- Offering size
- US$102 million
- Underwriters' option
- Up to 900,000 more shares
- Listing
- NPCE on the Nasdaq Global Market
- Underwriters
- J.P. Morgan, Morgan Stanley, Wells Fargo Securities, SVB Leerink · In the order on the cover
- Shares delivered
- On or about Apr 26, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 29, 2021 |
| Filed publicly | Mar 24, 2021 |
| Amended twice | Newest Apr 21, 2021 |
| Shares registered with an exchange | Apr 14, 2021 |
| Declared effective by the SEC | Apr 21, 2021 |
| Final prospectus, with the price | Apr 23, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 23, 2021 |
| EFFECT · Notice that a registration is effective | Apr 21, 2021 |
| S-1MEF · Registration of more shares for the same offering | Apr 21, 2021 |
| CORRESP · Letter to the SEC | Apr 21, 2021 |
| CORRESP · Letter to the SEC | Apr 21, 2021 |
| FWP · Free writing prospectus | Apr 21, 2021 |
| POS AM · Amendment to an effective registration | Apr 21, 2021 |
| EFFECT · Notice that a registration is effective | Apr 20, 2021 |
| CERT · Exchange's certificate of listing | Apr 20, 2021 |
| CORRESP · Letter to the SEC | Apr 16, 2021 |
All 20 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Apr 16, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 14, 2021 |
| S-1/A · Registration statement, amended | Apr 14, 2021 |
| CORRESP · Letter to the SEC | Apr 9, 2021 |
| UPLOAD · Letter from the SEC | Apr 7, 2021 |
| CORRESP · Letter to the SEC | Apr 6, 2021 |
| CORRESP · Letter to the SEC | Mar 24, 2021 |
| S-1 · Registration statement | Mar 24, 2021 |
| UPLOAD · Letter from the SEC | Feb 25, 2021 |
| DRS · Draft registration statement | Jan 29, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Apr 23, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 100.0M | 79.9M | 65.4M | 45.5M | 45.2M | 41.1M | 37.0M |
| Cost of revenue | 22.8M | 20.8M | 17.3M | 13.0M | 11.7M | 10.9M | 10.5M |
| Gross profit | 77.2M | 59.1M | 48.1M | 32.5M | 33.4M | 30.3M | 26.5M |
| Research and development | 27.9M | 23.7M | 20.8M | 21.9M | 18.2M | 15.7M | 18.3M |
| Selling, general and administrative | 19.1M | 57.1M | 54.5M | 51.3M | 39.0M | 27.6M | 30.2M |
| Operating income | -16.3M | -21.7M | -27.2M | -40.8M | -23.7M | -13.1M | -22.0M |
| Depreciation and amortization | 238.0K | 207.0K | 172.0K | 267.0K | 296.0K | 312.0K | 421.0K |
| EBITDA | -16.1M | -21.5M | -27.0M | -40.5M | -23.4M | -12.7M | -21.6M |
| Interest expense | 7.46M | 8.80M | 8.52M | 7.53M | 7.41M | 11.5M | 9.48M |
| Income before tax | -21.5M | -27.1M | -33.0M | -47.1M | -36.1M | -24.3M | -30.0M |
| Income tax | 0 | 1.44M | 6.29M | 2.03M | 11.7M | 10.8M | |
| Net income | -21.5M | -27.1M | -33.0M | -47.1M | -36.1M | -24.3M | -30.0M |
| Earnings per share, basic | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 | -117.85 | -2.70 |
| Earnings per share, diluted | -0.66 | -0.93 | -1.27 | -1.91 | -2.17 | -117.85 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 21.7M | 13.4M | 18.1M | 6.61M | 19.2M | 26.4M | 4.12M |
| Short-term investments | 39.4M | 39.3M | 48.4M | 70.8M | 96.4M | 11.7M | 969.0K |
| Receivables | 12.9M | 12.9M | 12.3M | 7.48M | 7.09M | 8.39M | 6.02M |
| Inventory | 14.9M | 13.4M | 11.2M | 9.71M | 7.82M | 6.91M | 7.90M |
| Current assets | 94.1M | 81.3M | 92.7M | 97.7M | 132.8M | 54.6M | 20.3M |
| Property, plant and equipment | 1.13M | 1.05M | 1.00M | 1.06M | 603.0K | 515.0K | 810.0K |
| Total assets | 105.6M | 94.6M | 107.7M | 114.1M | 133.6M | 56.0M | 21.1M |
| Accounts payable | 1.78M | 2.95M | 2.33M | 2.15M | 1.38M | 949.0K | 903.0K |
| Current liabilities | 17.8M | 15.2M | 16.2M | 11.0M | 9.30M | 9.60M | 75.1M |
| Long-term debt | 58.9M | 59.5M | 57.0M | 52.9M | 49.8M | 50.8M | |
| Total debt | 58.9M | 59.5M | 57.0M | 52.9M | 49.8M | 52.9M | 62.8M |
| Total liabilities | 86.5M | 86.6M | 87.0M | 79.3M | 60.1M | 62.4M | 150.4M |
| Shareholders' equity | 19.0M | 8.01M | 20.7M | 34.8M | 73.5M | -147.8M | -129.3M |
| Shares outstanding | 33.6M | 30.1M | 27.8M | 25.0M | 24.5M | 314.1K | 11.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -11.0M | -17.9M | -19.7M | -36.9M | -24.6M | -21.6M | -25.0M |
| Capital spending | -332.0K | -306.0K | -173.0K | -603.0K | -384.0K | -62.0K | -468.0K |
| Free cash flow | -11.3M | -18.3M | -19.9M | -37.5M | -25.0M | -21.7M | -25.5M |
| Cash from investing | -332.0K | 8.99M | 23.0M | 23.8M | -85.4M | -10.8M | 3.62M |
| Cash from financing | 19.6M | 4.33M | 8.13M | 490.0K | 102.5M | 55.0M | 21.4M |
| Share buybacks | -49.5M | 0 | -259.0K | -59.0K | 106.6M | ||
| Change in cash | 8.26M | -4.63M | 11.5M | -12.6M | -7.45M | 22.6M | -38.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 4, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 11, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 11, 2026 | Results | SEC |
| 8-K · Current report | Jul 28, 2026 | Current report | SEC |
| 4 · Change in ownership | Jun 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 8, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | May 15, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 12, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Apr 21, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 21, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 21, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 3, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 3, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 3, 2026 | Results | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 23, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 15, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 7, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 3, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 12, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 5, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 24, 2025 | Management or board change | SEC |
| 8-K · Current report | Jun 12, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 8-K · Current report | May 27, 2025 | Current report | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | May 15, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 13, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 22, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 22, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 22, 2025 | Meeting notice | SEC |
| 8-K · Current report | Apr 14, 2025 | Current report | SEC |
| 8-K · Current report | Apr 2, 2025 | Current report | SEC |
| 4 · Change in ownership | Mar 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 4, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 4, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 4, 2025 | Results | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 20, 2025 | Current report | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 18, 2025 | Current report | SEC |
| 424B5 · Prospectus | Feb 18, 2025 | Offer document | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Feb 14, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Feb 14, 2025 | Offer document | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 11, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 4, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 31, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 30, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 29, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jan 28, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 28, 2025 | Results | SEC |
| 144 · Notice of proposed sale | Jan 24, 2025 | Other filings | SEC |
| 8-K · Current report | Jan 15, 2025 | Current report | SEC |
| 4 · Change in ownership | Jan 8, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 8, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 8, 2025 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 4, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 28, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 28, 2024 | Other filings | SEC |
| 4 · Change in ownership | Oct 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 18, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 3, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 3, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 3, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2024 | Results | SEC |
| 4 · Change in ownership | Jun 11, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 10, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2024 | Results | SEC |
| 4 · Change in ownership | May 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 26, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2024 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 22, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 22, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 22, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 15, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 15, 2024 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Mar 5, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 5, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 5, 2024 | Results | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 7, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Feb 6, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 2, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 26, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 8, 2024 | Results | SEC |
| 4 · Change in ownership | Dec 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 20, 2023 | Other filings | SEC |
| 4 · Change in ownership | Dec 7, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 6, 2023 | Other filings | SEC |
This page holds 200 of 358 filings. Open Filings
Cap table
Built by 6ix from NeuroPace, Inc.’s releases · as of Nov 10, 2026
- Common shares
- 34,451,570
- Fully diluted
- 34,451,570
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 34,451,570 | Nov 10, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 10, 2026 | 34,451,570 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Scott Huennekens Other companies: QuidelOrtho Corporation (Director · Since at least Dec 6, 2024); Envista Holdings Corporation (Director · Since at least Sep 20, 2019); Hyperfine, Inc. (Director · Dec 22, 2021 – Jun 12, 2024 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); NuVasive Inc (Director · Oct 1, 2018 – Sep 1, 2023 · Past); EndoChoice Holdings Inc (Director · Jun 5, 2015 – Nov 22, 2016 · Past); Bellerophon Therapeutics Inc (Director · May 12, 2015 – May 12, 2015 · Past); Volcano Corp (President & Chief Executive Of, Director · Jun 14, 2006 – Feb 17, 2015 · Past) | Director · Since at least Jan 6, 2025 |
| Frank M Fischer Other companies: Tenon Medical, Inc. (Director · Apr 26, 2022 – May 22, 2023 · Past); Nevro Corp (Director · Nov 5, 2014 – Mar 31, 2024 · Past); Intralase Corp (Director · May 24, 2006 – Apr 2, 2007 · Past) | Director · Since at least Apr 20, 2021 |
| Joseph Lacob Other companies: Align Technology, Inc. (Director · Since at least May 24, 2006); Orexigen Therapeutics Inc (Director · Apr 25, 2007 – May 27, 2011 · Past); eHealth, Inc. (Director · Oct 12, 2006 – Nov 8, 2007 · Past) | Director · Since at least Apr 20, 2021 |
| Patrick F. Williams Other companies: BioRestorative Therapies, Inc. (Director · Nov 4, 2021 – Feb 14, 2025 · Past); STAAR Surgical Company (Chief Financial Officer · Jul 6, 2020 – Mar 12, 2025 · Past); Sientra Inc (General Manager miraDry & SVP · Jan 19, 2018 – Aug 6, 2018 · Past) | Chief Financial Officer · Since at least Jun 20, 2025 |
| Joel D. Becker Other companies: Integer Holdings Corporation (President, CRM & Neuro · Apr 22, 2019 – Apr 22, 2022 · Past); St. Jude Medical Inc (President, Americas · Oct 31, 2011 – Dec 17, 2015 · Past) | CEO and Board Member · Since at least Jul 10, 2023 |
| Rakhi Kumar Other companies: Amanat Acquisition Corp (Director · Since at least May 18, 2026); Roivant Sciences Ltd. (Chief Accounting Officer · Oct 24, 2023 – Feb 20, 2025 · Past) | Director · Since at least Jun 7, 2024 |
| Uri Geiger Other companies: STRATA Skin Sciences, Inc. (Director · Jul 15, 2024 – Jul 15, 2024 · Past); Minerva Surgical, Inc. (Director · Feb 9, 2023 – Feb 9, 2023 · Past) | Director · Since at least Jan 5, 2023 |
| Greg Shaw Garfield Other companies: Semler Scientific Inc (Director · Feb 20, 2014 – Feb 18, 2016 · Past) | Director · Apr 20, 2021 – Jun 13, 2022 · Past |
| Evan Norton | Director · Apr 20, 2021 – Apr 26, 2021 · Past |
| Irina Ridley | Chief Legal Officer/Secretary · Apr 20, 2021 – Feb 20, 2023 · Past |
All 17 people
| Person | Seat |
|---|---|
| Leah Akin | General Counsel & Corporate Secretary · Since at least Nov 5, 2026 |
| Lisa Andrade | Director · Since at least Jun 7, 2024 |
| Martha Morrell | Chief Medical Officer · Since at least Apr 20, 2021 |
| Michael Favet | Chief Executive Officer, Director · Apr 20, 2021 – Feb 21, 2023 · Past |
| Rebecca Kuhn | CHIEF FINANCIAL OFFICER · Since at least Apr 20, 2021 |
| Renee Ryan | Director · Since at least Apr 20, 2021 |
| Scott Schaper | Head of Investor Relations · Since at least Sep 1, 2026 |
Log in to ask 6ix AI your own questions about NeuroPace, Inc.